Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concizumab improves clot formation in hemophilia A under flow.
Jewell MP, Ashour Z, Baird CH, Manco Johnson M, Warren BB, Wufsus AR, Pallini C, Dockal M, Kjalke M, Neeves KB. Jewell MP, et al. Among authors: dockal m. J Thromb Haemost. 2024 Sep;22(9):2438-2448. doi: 10.1016/j.jtha.2024.05.020. Epub 2024 May 28. J Thromb Haemost. 2024. PMID: 38815755
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
Rossato P, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Rottensteiner H, Gritsch H, Federti E, Matte A, De Franceschi L, Scheiflinger F, Hoellriegl W. Rossato P, et al. Among authors: dockal m. J Thromb Haemost. 2023 Feb;21(2):269-275. doi: 10.1016/j.jtha.2022.10.016. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36700507 Free article.
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi L. Rossato P, et al. Among authors: dockal m. Haematologica. 2022 Nov 1;107(11):2650-2660. doi: 10.3324/haematol.2021.280233. Haematologica. 2022. PMID: 35443560 Free PMC article.
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.
Glantschnig H, Bauer A, Benamara K, Dockal M, Ehrlich V, Gritsch H, Höbarth G, Horling FM, Kopic A, Leidenmühler P, Reipert BM, Rottensteiner H, Ruthsatz T, Schrenk G, Schuster M, Turecek PL, Weber A, Wolfsegger M, Scheiflinger F, Höllriegl W. Glantschnig H, et al. Among authors: dockal m. J Pharmacol Exp Ther. 2019 Oct;371(1):95-105. doi: 10.1124/jpet.119.260067. Epub 2019 Jul 31. J Pharmacol Exp Ther. 2019. PMID: 31366602
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králíčková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL; COMPACT Investigators. Longhurst H, et al. N Engl J Med. 2017 Mar 23;376(12):1131-1140. doi: 10.1056/NEJMoa1613627. N Engl J Med. 2017. PMID: 28328347 Free article. Clinical Trial.
Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S, Thomassen S, Heinzmann A, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M, Rosing J. Peraramelli S, et al. Among authors: dockal m. Thromb Haemost. 2016 Mar;115(3):580-90. doi: 10.1160/TH15-04-0354. Epub 2015 Nov 26. Thromb Haemost. 2016. PMID: 26607136
43 results